International | Tissuepathology.com

Aiforia Announces Upcoming Webinar

Erica Goodpaster — Fri, 03 Apr 2026 12:17:25 +0000

Aiforia: AI model development used to be a marathon of data and time, but we have built a shortcut. Join Aiforia’s CPO and Director of Software Development to discover how Aiforia’s Foundation Engine elevates your research and diagnostics. Why Aiforia’s Foundation Engine is advancing digital pathology Thursday, April 16, 2026 | 5-6 pm CEST | 6-7 […]

The post Aiforia Announces Upcoming Webinar first appeared on Tissuepathology.com.

CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP

Erica Goodpaster — Wed, 01 Apr 2026 12:30:34 +0000

CorePlus and Ibex: Digital pathology leader surpasses 250,000 AI-based analyses in routine clinical use as it incorporates Ibex Prostate for TURP to further enhance diagnostic precision. CAROLINA, Puerto Rico & BOSTON–(BUSINESS WIRE)–CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high-complexity CLIA-certified laboratory and global leader in digital transformation, and Ibex Medical Analytics (Ibex), a pioneer […]

The post CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP first appeared on Tissuepathology.com.

Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

Erica Goodpaster — Mon, 30 Mar 2026 12:46:21 +0000

Lunit, CellCarta: Partnership combines Lunit’s platform-agnostic AI pathology algorithms with CellCarta’s global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence generation and CDx launch pathways. SEOUL, South Korea and MONTREAL, March 30, 2026 /PRNewswire/ — Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, and CellCarta, a […]

The post Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs first appeared on Tissuepathology.com.

Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials

Erica Goodpaster — Tue, 24 Mar 2026 13:57:05 +0000

Discovery Life Sciences and Mindpeak: New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent challenge in drug development HUNTSVILLE, Ala. and HAMBURG, Germany, March 24, 2026 /PRNewswire/ — Inconsistent biomarker interpretation across pathologists remains one of the more stubborn challenges in clinical trial development, contributing to variability in patient stratification and eroding confidence in […]

The post Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials first appeared on Tissuepathology.com.

Leica Biosystems and Bio-Techne Announce the US Launch of RNAscope In Situ Hybridization Automation on the BOND-PRIME Staining Platform

Erica Goodpaster — Thu, 19 Mar 2026 11:56:25 +0000

Melbourne, Australia — (March 17, 2026) — Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, and Bio-Techne (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, announce the US launch of BOND-PRIME RNAscope Brown Detection, enabling automation of RNAscope™ in situ hybridization (ISH) on the BOND-PRIME IHC/ISH staining […]

The post Leica Biosystems and Bio-Techne Announce the US Launch of RNAscope In Situ Hybridization Automation on the BOND-PRIME Staining Platform first appeared on Tissuepathology.com.

Aiforia announces the next generation of its CE-IVD marked Prostate Cancer Biopsy AI solution

Erica Goodpaster — Wed, 18 Mar 2026 13:05:44 +0000

The Aiforia Prostate Cancer Biopsy AI application is designed to enhance pathologists’ diagnostic workflow by providing world-class tools for comprehensive analysis and reporting of prostate needle biopsies. Aiforia Technologies Plc, Press Release, March 17, 2026 at 9:30 a.m. EET Aiforia Technologies Plc today announced the launch of the next generation of its clinical AI solution […]

The post Aiforia announces the next generation of its CE-IVD marked Prostate Cancer Biopsy AI solution first appeared on Tissuepathology.com.